Furthermore, Tam treatment prevented HFD-induced obesity in OVX AF2ERKI females, suggesting that ERα AF-1 can control metabolic regulation without AF-2 activation but not the accompanying insulin insensitivity commonly seen in metabolic syndrome. This evidence concerns the gene ESR1 and obesity disorder.